The incidence of cardiac arrhythmias has become so high that new technologies must be included in the production of electrophysiological devices. The widespread use of minimally invasive electrophysiology therapy has been made possible by requiring highly precise and regulated cardiac diagnostic and ablation methods.
Additionally, interventionalists are now using disposable catheters for intermittent cardiac procedures since they are more sterile, safe, and affordable.
With the arrival of cutting-edge electrophysiological technologies, an increase in cardiac ablation treatments, and supportive payment policies, the need for electrophysiology is anticipated to grow steadily.
Thus, the global electrophysiology industry will reach $17,482.7 million by 2030. This can be attributed to technological developments, growth in the demand for diagnostic and ablation catheters, and increase in the prevalence of atrial fibrillation in older people.
A major cause of mortality, according to the World Health Organization (WHO), is cardiac problems, which are grave health issues. The therapy of cardiac arrhythmias involves using several interventional techniques and implanted cardiac devices.
 |
| Get the sample pages of this report: https://bit.ly/3S1XVmS |
Highest Revenue Was Generated by Sale of Ablation Catheters
The category of ablation catheters now has the biggest share. With the help of catheters, damaged electrical circuits in the heart are eliminated during ablation, a minimally invasive procedure.
The device can be utilized to remove abnormal cardiac tissue that contributes to abnormal heart rhythms. The two ablation catheter methods that are most often employed are radiofrequency and cryoablation, and as technology progresses, their use is projected to increase significantly.
Technological Advances are driving Demand in Electrophysiology Devices
The burden of heart disorders has decreased due to changes in treatment methods for cardiac arrhythmias brought about by technological improvements.
The patient pool is expected to grow globally as the aging population surges. This is anticipated to fuel the electrophysiological ablation catheter market during the next few years. CVDs are the leading cause of mortality worldwide, according to the WHO.
About 32% of all fatalities worldwide occurred due to CVDs in the previous year, killing approximately 17.9 million individuals. An estimated 85% of these fatalities were attributed to heart attacks and strokes.
During the projected period, there is anticipated to be an increase in the need for electrophysiology ablation catheters due to the rise in the prevalence of cardiovascular illnesses in the geriatric population.
Cardiac and Hospitals Centers Has Largest Share
The biggest end customers of electrophysiology products are hospitals and cardiac facilities. As a result, the category now has the biggest share in the electrophysiology market.
Additionally, this is a result of an increase in the number of ablation operations performed in public and private hospitals worldwide and increased utilization of electrophysiology and Cath labs.
Hospital-based care is in great demand due to the availability of state-of-the-art facilities for disease diagnosis and treatment and competent employees. Compared to other medical facilities, hospitals do more screening and diagnostic procedures, which results in a significant share.
Additionally, due to the development of superior electrophysiological products and the demand for minimally invasive treatments, the use of electrophysiology devices in various healthcare settings is increasing.
No comments:
Post a Comment